Sangamo BioSciences | SGMO - Selling And Administration Expenses


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Sangamo BioSciences

Sangamo BioSciences reported $18.14M in Selling and Administration Expenses for its fiscal quarter ending in March of 2023.


Selling And Administration Expenses Change
Alaunos Therapeutics Inc ZIOP:US USD 3.17M 243K
Alnylam Pharmaceuticals ALNY:US USD 183.66M 26.68M
Amgen AMGN:US USD 1.26B 210M
Avrobio Inc AVRO:US USD 7.89M 767K
Bayer BAYN:GR EUR 4.05B 374M
BioCryst Pharmaceuticals BCRX:US USD 47.87M 2.29M
Biogen BIIB:US USD 605M 27.8M
BioMarin Pharmaceutical BMRN:US USD 223M 22.74M
Bluebird Bio BLUE:US USD 37.35M 6.65M
Gilead Sciences GILD:US USD 1.32B 702M
GlaxoSmithKline GSK:LN GBP 2.06B 370M
Intercept Pharmaceuticals ICPT:US USD 57.66M 2.37M
Ionis Pharmaceuticals IONS:US USD 45.52M 2.43M
J&J JNJ:US USD 6.14B 374M
Karyopharm Therapeutics KPTI:US USD 35.91M 1.26M
Merck & Co MRK:US USD 2.46B 209M
Novartis NOVN:VX USD 3.4B 298M
Pfizer PFE:US USD 3.49B 1.39B
Regulus Therapeutics RGLS:US USD 2.44M 225K
Roche Holding ROG:VX 6.48B 834M
Sangamo BioSciences SGMO:US USD 18.14M 1.69M
Sarepta Therapeutics SRPT:US USD 110.71M 9.76M
Ultragenyx Pharmaceutical RARE:US USD 76.65M 3.8M
Vertex Pharmaceuticals VRTX:US USD 241.1M 26.3M